Thermo Fisher Scientific has raised $750 million in a two-part note sale through a private placement, The Wall Street Journal reports. The first tranche, worth $350 million, will mature on Dec. 28, 2012 and offer a coupon of 2.15%.

The second tranche, worth $400 million, matures Nov. 18, 2014, and will offer a coupon of 3.25%. The active bookrunning managers for the sale were Bank of America and Barclays, while JP Morgan, Deutsche Bank, and Royal Bank of Scotland were the passive bookrunning managers for the sale, adds Reuters.

Click here for the story from The Wall Street Journal.

Click here for additional coverage from Reuters.